Fingerprint
Dive into the research topics of 'A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (Bortezomib, Velcade), in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically